The potential use of mesenchymal stem cells and their exosomes in Parkinsons disease treatment
Shortages of weight loss medication forecast for 2024 Ahead of Mounjaro's launch in Australia, Eli Lilly was optimistic that supply would be able to meet demand in the market
After that, a doctor may increase the dose depending on blood sugar response and tolerability
GLPs (glucagon-like peptide-1 receptor agonists) are medications that mimic the natural hormone, glucagon
I've yet to speak to a patient, friend, family member using one of these weight-loss drugs who hasn't had some element of those side effects, either individually or in combination
Risk Factors for Polypharmacy There are two main categories of risk factors contributing to polypharmacy: those related to patients and those associated with the healthcare system (1,4-6)